Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
about
Role of guanine-nucleotide exchange factor Epac in renal physiology and pathophysiologySodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effectsUpdate on the treatment of type 2 diabetes mellitusProximal nephronProteomic analysis of brush-border membrane vesicles isolated from purified proximal convoluted tubules.Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.The Sweet Pee model for Sglt2 mutationSodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology.The pathophysiology of hypertension in patients with obesity.Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathwayFunctional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats.Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathy.SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes.Canagliflozin, a novel SGLT2 inhibitor for treatment of type 2 diabetes.Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes.Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus : A comprehensive summary for antidiabetic drugs.Antidiabetic Effect of Schisandrae Chinensis Fructus Involves Inhibition of the Sodium Glucose Cotransporter.Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation.EGF regulation of proximal tubule cell proliferation and VEGF-A secretion.MAP17, a ROS-dependent oncogene.Achievements and challenges in bioartificial kidney development.Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells.Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?Antihyperglycemic effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, in combination with oral antidiabetic drugs in mice.
P2860
Q27003242-EF3BD7C1-EE39-4B66-AC62-4999E77B1A12Q28072765-1524A81B-A2A6-4740-959A-23C2C55379FDQ28073342-DE927296-C661-4765-86C7-1B553D672C9BQ28388052-CF3379D6-5B0D-4AD6-B399-0631E4906D62Q33917792-204E72A1-0539-4F13-81C1-1166345F3395Q34120717-C8FAAB36-7A2D-4B30-B246-C44B6F053541Q34457273-65CD67D4-24AF-4512-B063-DC61D0FBB57FQ34726437-B52592EB-CBE8-400B-9BF3-DB06B2A68FB0Q35021492-99B6DA51-24B6-4474-9A7E-DAA873A21996Q35111555-6F58CF64-08CB-4910-AFB1-2CD5FC24FFAEQ35235683-4DCC53D9-79D1-467D-9EAD-D0E73A524C28Q36309350-D8F70B71-24BD-460F-907E-1009468A79B0Q37022726-8829409A-66E4-45B0-8F3C-0FF8A9D778F1Q37120357-05EE4727-97BB-4FB2-BD57-05EC96D2F09EQ37820693-64A9E82D-5241-465A-8B6F-E38F12922A2BQ38104746-62E5B771-AE89-4A16-A1D5-DC57D930135AQ38126109-ED304398-0EEC-44D7-98C4-CD1FDB9731D0Q38130748-6B34DD28-5BE3-44D0-8684-167110E89A11Q38164682-29EEC228-D5C5-43F4-AF0F-9C78C0B6E8ADQ38205581-72937B58-9275-4F85-9726-DA24CF59B9EBQ38845574-DCB49C56-D2F7-4D3A-A961-8D5A49946C67Q38939488-34DCF999-6642-493D-A331-847115E480C7Q38975736-01C7C102-0721-4922-9620-489C8C1F4CE5Q41227936-AD3C06B0-BFBC-4595-B238-585B79941FCEQ42093775-83435672-859D-49B3-ACEC-A2909BFBDACFQ42323237-2E195AF9-F010-4FB8-8E2F-AA6DB676F8EAQ42523299-9C05E242-F3DC-45E3-893E-34B439EAEF83Q43218265-CD73B439-13F7-4728-9C36-01208C4FED15Q46124638-F5C64889-9A4E-4265-AAD0-C17418FBBA30Q46346105-0B64B615-B76A-4366-82DD-C3A1C97E0B23Q51043340-23FCA8C8-3D9E-4B47-9E68-54DF4128108C
P2860
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
@en
type
label
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
@en
prefLabel
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
@en
P356
P1476
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells
@en
P2093
P304
P356
10.1038/SJ.KI.5002383
P50
P577
2007-08-01T00:00:00Z